The Acute Dialysis Quality Initiative--part V: operational characteristics of CRRT.

This report represents the consensus statement of the ADQI workgroup addressing the operational characteristics of continuous renal replacement therapy (CRRT). Issues addressed included the specific operational characteristics of continuous hemofiltration (HF), continuous hemodialysis (HD), and continuous hemodiafiltration (HDF) and the impact of these different modalities on solute removal. The relative roles of arteriovenous (AV) and venovenous (VV) modalities of therapy were also evaluated. The workgroup also addressed the optimal components of a CRRT system from an operational standpoint.

[1]  S. Brunet,et al.  Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  R Jenkins,et al.  Accuracy of Intravenous Infusion Pumps in Continuous Renal Replacement Therapies , 1992, ASAIO journal.

[3]  C. Stoutenbeek,et al.  Cytokine Filtration and Adsorption during Pre- and Postdilution Hemofiltration in Four Different Membranes , 1998, Blood Purification.

[4]  H. Kierdorf,et al.  Is cytokine removal by continuous hemofiltration feasible? , 1999, Kidney international. Supplement.

[5]  S. Goldfarb,et al.  Proinflammatory cytokines and hemofiltration membranes. , 1994, Journal of the American Society of Nephrology : JASN.

[6]  N. Maxvold,et al.  Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis , 2000, Critical care medicine.

[7]  M. A. Marx,et al.  Drug dosing adjustments during continuous renal replacement therapies. , 1998, Kidney international. Supplement.

[8]  S. Vas,et al.  Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. , 1988, Clinical nephrology.

[9]  C. Ronco,et al.  Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. , 1995, Critical care medicine.

[10]  John P. Johnson,et al.  Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. , 1998, Critical care medicine.

[11]  B. Canaud,et al.  Pump assisted continuous venovenous hemofiltration for treating acute uremia. , 1988, Kidney international. Supplement.

[12]  D. Inthorn,et al.  Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure , 1991, The Lancet.

[13]  W. Macias,et al.  Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  A. Sedman,et al.  Continuous venovenous hemodiafiltration in infants and children. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  R. Bellomo,et al.  Continuous renal replacement therapy: evolution in technology and current nomenclature. , 1998, Kidney international. Supplement.

[16]  A. Greenberg,et al.  Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. , 1992, ASAIO journal.

[17]  M Roberts,et al.  Errors in Fluid Balance with Pump Control of Continuous Hemodialysis , 1992, The International journal of artificial organs.

[18]  C. Ronco,et al.  Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  P. Palevsky,et al.  Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  P. Palevsky,et al.  Determinants of Ceftriaxone Clearance by Continuous Venovenous Hemofiltration and Hemodialysis , 2000, Pharmacotherapy.

[21]  P. Palevsky,et al.  Determinants of Ceftazidime Clearance by Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodialysis , 2000, Antimicrobial Agents and Chemotherapy.

[22]  H. Bruining,et al.  Cytokine Kinetics (TNF-α, IL-1β, IL-6) during Continuous Hemofiltration: A Laboratory and Clinical Study , 1995 .

[23]  J. De Sutter,et al.  Cytokine removal during continuous hemofiltration in septic patients. , 1999, Journal of the American Society of Nephrology : JASN.

[24]  G. Camussi,et al.  Production of platelet-activating factor in patients with sepsis-associated acute renal failure. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.